Axon Enterprise Inc. stock pulls back sharply amid AI defense demand reassessment

Axon Enterprise Inc. (ISIN: US05464C1018) shares on Nasdaq declined 9.99% to US$456.60 as investors digest recent valuation pressures despite robust FY2025 results and analyst targets above $700. The public safety leader benefits from rising AI and defense spending, but high multiples spark debate on growth sustainability for US investors.

Axon Enterprise Inc. stock experienced a sharp pullback, dropping 9.99% on Tuesday, March 24, 2026, to close at US$456.60 on Nasdaq. This move follows a 10.19% decline over the past week, contrasting with longer-term gains including a 110.58% total shareholder return over three years. Investors are reassessing the stock's premium valuation amid broader growth sector compression, even as the company's AI-powered platforms gain traction in public safety and defense.

As of: 25.03.2026

By Elena Voss, Senior Defense Tech Analyst: Axon Enterprise Inc. exemplifies how AI integration is reshaping public safety ecosystems, positioning the Nasdaq-listed firm for sustained demand from US law enforcement and military budgets.

Recent Price Action Signals Short-Term Caution

The Axon Enterprise Inc. stock fell from US$507.28 to US$456.60 on Nasdaq in the last trading session, marking a 9.99% single-day drop. This comes after opening at US$501.47 on Wednesday, with the stock navigating a 52-week range from a low of US$396.41 to a high of US$885.92. The 50-day moving average hovers around levels that suggest the current pullback tests key support near US$450-US$500 as of late March 2026.

Market participants point to valuation compression across high-growth tech names as the primary driver. After hitting an all-time high of US$885.92 in mid-2025, the stock has corrected amid rising interest rate expectations and profit-taking. Yet, technical indicators show the stock in a rising short-term trend, with potential support from accumulated volume at levels like US$732.99 from prior sessions.

For US investors, this dip raises questions about entry points. The stock's position in the lower part of its trend channel could signal a buying opportunity if defense spending ramps up, but volatility remains medium with daily fluctuations around 4-5% observed recently.

Strong FY2025 Results Underpin Long-Term Bull Case

Axon Enterprise Inc. reported record fiscal 2025 revenue of US$2.78 billion, up 33% year-over-year, with annual recurring revenue (ARR) exceeding US$1.35 billion, a 35% increase. Gross margins hit 62% overall, driven by the software and services segment's 82% margin, while contracted backlog reached US$14.4 billion. The company ended the year with over US$1.1 billion in cash, supporting ongoing R&D and acquisitions like Carbyne.

These figures highlight Axon's shift from hardware roots, such as TASER devices, to a software-centric public safety platform. Cloud-based evidence management, connected policing tools, and AI integrations now dominate revenue streams, reducing cyclicality tied to device sales. Free cash flow positivity amid heavy reinvestment underscores operational leverage.

US investors should note the 'defensive growth' profile: public safety budgets prove resilient even in downturns, backed by institutional holders like BlackRock and Vanguard. This positions Axon as a stable high-growth play in uncertain markets.

AI and Defense Tailwinds Drive Investor Interest

Expectations around US defense spending are fueling focus on Axon's AI-powered Fusus and Drone as First Responder platforms. These tools target law enforcement and military customers, aligning with rising budgets for public safety tech. Investors see Axon transforming into an ecosystem for digital evidence and connected tools, beyond legacy TASER associations.

The narrative fair value estimate of US$606.83 implies 24.8% undervaluation at US$456.60 on Nasdaq, per analysis models. This gap reflects optimism for AI-driven demand in defense and policing, where hyperscaler-like growth meets essential services. Sector peers trade at lower P/S multiples of 4.6x, versus Axon's 13.2x, pricing in execution on software expansion.

For US investors, federal and state procurement cycles amplify relevance. Platforms like Fusus integrate real-time data analytics, appealing to agencies prioritizing AI for threat detection and response efficiency.

Analyst Consensus Points to Significant Upside

Wall Street maintains a moderately bullish stance, with 14 buy ratings and 4 holds among 18 analysts. Average 12-month price targets range from US$762.93 to US$841.64, suggesting 14.36% to over 80% upside from US$456.60 on Nasdaq. High-end targets reach US$1,000, while lows sit at US$700.

Recent activity includes one upgrade and one downgrade in the past 90 days, reflecting balanced views on volatility. Institutional buying, such as Invesco's position, signals confidence. Retail sentiment on platforms labels Axon a 'forever hold' due to moat strength in public safety essentials.

US investors benefit from this coverage depth, as targets incorporate AI monetization and backlog conversion. Consensus outperforms aerospace peers on predicted upside, with positive news sentiment.

Why US Investors Should Watch Closely Now

Axon Enterprise Inc. offers US investors exposure to resilient public safety demand, insulated from consumer cyclicality. With over US$55 billion market cap, the firm holds strong industry positioning amid budget stability. Recent insider purchases signal management alignment, countering volatility concerns.

Key for portfolios: Axon's software shift mirrors cloud leaders, with ARR growth outpacing revenue. Defense exposure taps multi-year US spending increases, while domestic law enforcement adoption drives stickiness. At current levels post-correction, the stock presents a potential entry for growth-oriented accounts.

Compared to S&P 500, Axon's moderate buy rating scores higher, with superior upside forecasts. This makes it compelling for balancing tech growth with defensive qualities in 2026 portfolios.

Risks and Open Questions Ahead

High P/E ratios around 173x raise overvaluation flags for value investors, especially with recent 4.2% drops highlighting volatility. Execution risk looms on AI platform scaling and acquisition integration, like Carbyne. Competition in aerospace and defense could pressure margins if pricing power erodes.

Broader risks include regulatory scrutiny on policing tech and potential budget delays. While backlog supports visibility, conversion depends on deployment timelines. Investors must weigh premium multiples against growth durability in a higher-rate environment.

Short-term trend breaks below US$708 could signal slower rises, per technicals. Bear case emphasizes volatility and rich valuations, advising caution for risk-averse holders.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.